ESC 365 - Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease

ESC Professional Premium Access

Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease

Session: Arterial occlusive disease: a chronic pandemic needing attention to detail

Topic: Pathophysiology and Mechanisms

Speaker: Doctor M. Bonaca (Aurora, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

29 presentations

1 follower

8 more presentations in this session

Reduction in the risk of major adverse limb events with ezetimibe versus placebo in addition to statin therapy: insights from the IMPROVE IT trial

Speaker: Doctor M. Bonaca (Aurora, US)

The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020

Speaker: Professor C. Hehrlein (Freiburg, DE)

Association between electronic nicotine delivery systems use and risk of stroke: A systematic review and meta-analysis of observational studies with 822,162 participants.

Speaker: Professor M. Banach (Lodz, PL)

Olive extract enriched with hydroxytyrosol improves cardiac and vascular function in patients with stable coronary artery disease: a double-blind, placebo-controlled trial.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Of mice and men: transcriptome-based clustering reveals molecular heterogeneity among mouse atherosclerosis models and partially reflects the diversity of human plaques

Speaker: Mr E. Brouwer (Utrecht, NL)

Access the full session

Arterial occlusive disease: a chronic pandemic needing attention to detail

Speakers: Doctor M. Bonaca, Doctor M. Bonaca, Professor C. Hehrlein, Professor M. Banach, Doctor I. Ikonomidis...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by